Client: A Pharmaceutical Company
Challenge:
A pharmaceutical company sought to create communication materials for medical sales visits and scientific exchange meetings to raise awareness of the relationship between two clinical conditions. The objective was to highlight data on epidemiology, risk factors, and the importance of monitoring patients with one condition for potential development of the other.
Solution Provided by Clevidence:
Clevidence was engaged to develop effective communication materials, including a literature scoping review and a slide deck:
- Scoping Review of the Literature:
Our team conducted a scoping review to identify evidence regarding the relationship between the two conditions, focusing on:
Peer-reviewed articles and epidemiological studies on the connection.
Insights on prevalence, risk factors, and outcomes. - Assessment of Available Evidence:
We evaluated the quality of findings by:
Synthesizing data to highlight key associations.
Understanding implications for patient monitoring and management. - Defining Key Messages:
Based on the evidence, we crafted impactful key messages tailored for both medical sales representatives and Medical Science Liaison (MSL) professionals, emphasizing:
The importance of awareness and monitoring. - Medical Writing for Slide Deck:
We assembled the findings into a professional slide deck for medical sales visits and scientific exchange meetings, ensuring:
Engaging and clear communication of the data.
Results:
The communication materials equipped the pharmaceutical company with tools to raise awareness about the relationship between the two conditions. Key outcomes included:
An informative slide deck that enhanced the knowledge of medical sales representatives and MSL professionals. Positive feedback from stakeholders on the value of the materials.
Conclusion:
Through thorough research and strategic communication, Clevidence enabled the pharmaceutical company to effectively engage healthcare professionals, fostering improved patient monitoring and management strategies.